OCULAR THERAPEUTIX, INC Class of Warrant or Right, Outstanding
OCULAR THERAPEUTIX, INC (OCUL) had Class of Warrant or Right, Outstanding of 0 shares as of 2023-12-31, per its 10-K filed 2024-03-11.
Discontinued › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2024-03-11
- 2023-12-31: Class of Warrant or Right, Outstanding 0.00 shares.
- 2022-12-31: Class of Warrant or Right, Outstanding 0.00 shares.
- 2021-12-31: Class of Warrant or Right, Outstanding 0.00 shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2023-12-31 | 0.00 shares 10-K · filed 2024-03-11 |
| 2022-12-31 | 0.00 shares 10-K · filed 2024-03-11 |
| 2021-12-31 | 0.00 shares 10-K · filed 2023-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |